Advancing Small Molecules: Managing Complexity From Development Through Commercialization
Small molecules remain central to pharmaceutical innovation, but the development process is changing.
This white paper examines how AI-enabled route scouting, high-throughput experimentation and modern analytics help manage the growing complexity of small molecule APIs from early development to commercial supply.
This white paper examines how AI-enabled route scouting, high-throughput experimentation and modern analytics help manage the growing complexity of small molecule APIs from early development to commercial supply.
The Changing Small Molecule Landscape
Modern APIs carry challenging physicochemical properties, multiple chiral centers and demanding synthesis routes, requiring more sophisticated development approaches and analytical tools.
AI-Enabled Route Scouting
AI tools can evaluate thousands of potential synthesis routes in hours, helping chemists identify the most promising pathways for further development.
High-Throughput Experimentation
HTE platforms screen large numbers of reaction conditions in parallel, shortening process development timelines and identifying robust, scalable conditions for difficult transformations.
From Development to Commercialization
A clear line of sight from early development to commercial manufacturing ensures that development decisions are made with commercial scale in mind, reducing the risk of costly late-stage changes.
Download This White Paper
Biotechnology Media Insights
Continue to Biotechnology Media Insights to access this white paper.